Transportation Costs Impede Sustained Adherence and Access to HAART in a Clinic Population in Southwestern Uganda: A Qualitative Study
Top Cited Papers
Open Access
- 13 March 2009
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 14 (4), 778-784
- https://doi.org/10.1007/s10461-009-9533-2
Abstract
The cost of transportation for monthly clinic visits has been identified as a potential barrier to antiretroviral (ARV) adherence in sub-Saharan Africa and elsewhere, although there is limited data on this issue. We conducted open-ended interviews with 41 individuals living with HIV/AIDS and attending a clinic in Mbarara, Uganda, to understand structural barriers to ARV adherence and clinical care. Almost all respondents cited the need to locate funds for the monthly clinic visit as a constant source of stress and anxiety, and lack of money for transportation was a key factor in cases of missed doses and missed medical appointments. Participants struggled with competing demands between transport costs and other necessities such as food, housing and school fees. Our findings suggest that transportation costs can compromise both ARV adherence and access to care. Interventions that address this barrier will be important to ensure the success of ARV programs in sub-Saharan Africa.Keywords
This publication has 25 references indexed in Scilit:
- Predictors of Adherence to Antiretroviral Therapy in Rural ZambiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited SettingJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- From Directly Observed Therapy to Accompagnateurs: Enhancing AIDS Treatment Outcomes in Haiti and in BostonClinical Infectious Diseases, 2004
- Scaling-up HIV treatment programmes in resource-limited settingsAIDS, 2004
- Higher Baseline Levels of Plasma Human Immunodeficiency Virus Type 1 RNA Are Associated with Increased Mortality after Initiation of Triple‐Drug Antiretroviral TherapyThe Journal of Infectious Diseases, 2003
- Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in BotswanaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Adherence is not a barrier to successful antiretroviral therapy in South AfricaAIDS, 2003
- The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyAIDS, 2002
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Pathologies of power: rethinking health and human rights.American Journal of Public Health, 1999